Preclinical characterization and clinical translation of pharmacodynamic markers for MK-5890: a human CD27 activating antibody for cancer immunotherapy

Authors: David Rosen, Laurence Fayadat-Dilman, Yiwei Zhang, Konstantin Dobrenkov, Elliot Chartash, Richard Wnek, Smita Mauze, Hans van Eenennaam, Judith Stammen-Vogelzangs, Ying Yu, Marco Guadagnoli, Lars Guelen, Thierry O Fischmann, Jerelyn Wong, Nikolina Bąbała, Jozef Wagenaars, Veronica Juan, Winnie Prosise, Maurice Habraken, Imke Lodewijks, Danling Gu, Jeanne Baker, David Lutje Hulsik, Lilian Driessen-Engels, Dan Malashock, Joost Kreijtz, Astrid Bertens, Evert de Vries, Astrid Bovens, Arne Bramer, Sean Troth, Svetlana Sadekova, Andrea van Elsas, Jason K Cheung, Jannie Borst, Amy M Beebe

Source: Journal for ImmunoTherapy of Cancer, Vol 10, Iss 9 (2022)

Subject Terms: Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282

File Description: electronic resource

Relation: https://jitc.bmj.com/content/10/9/e005049.full; https://doaj.org/toc/2051-1426

Access URL: https://doaj.org/article/cc59fd0a12e04837b4168ce751ae8a2b

Development of Pandemic Vaccines: ERVEBO Case Study

Authors: Jayanthi Wolf, Risat Jannat, Sheri Dubey, Sean Troth, Matthew T. Onorato, Beth-Ann Coller, Mary E. Hanson, Jakub K. Simon

Source: Vaccines, Vol 9, Iss 3, p 190 (2021)

Subject Terms: Ebolavirus vaccine, rVSVΔG-ZEBOV-GP, vaccine development, regulatory strategy, vaccine manufacturing, Medicine

File Description: electronic resource

Relation: https://www.mdpi.com/2076-393X/9/3/190; https://doaj.org/toc/2076-393X

Access URL: https://doaj.org/article/94c5c7b69e2a4babbf8d53ab4442cb6a